Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pharmacokinetics of flavopiridol in patients

March 18, 1997

Differentiation-inducing retinoid-related compounds disclosed by Eisai

March 18, 1997

OXiGENE reports favorable preclinical results with Neu-Sensamide and Oxi-104

March 17, 1997

Anticancer agent from Banyu heading for clinic

March 14, 1997

Protein tyrosine kinase inhibitors from Glaxo Wellcome

March 14, 1997

Initial clinical results with LGD-1069

March 14, 1997

Pharmacopeia achieves milestone in collaboration with Schering-Plough

March 13, 1997

Matrix's radiation enhancer enters phase I/II

March 13, 1997

Antiestrogenics from Schering AG

March 13, 1997

U.S. patent for Sugen's lead cancer therapeutic

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...